(Q24805756)

English

Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421

scientific article

In more languages

Statements

scholarly article

0 references

Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN4119421 (English)

0 references

author name string

Thomas W Meade

1

0 references

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 July 2001

0 references

Current controlled trials in cardiovascular medicine

1 reference

2

0 references

195-204

0 references

4

0 references

https://scigraph.springernature.com/pub.10.1186/cvm-2-4-195

0 references

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

7 April 2017

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

7 April 2017

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

7 April 2017

Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 September 2017

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 September 2017

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 September 2017

Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

30 May 2018

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

30 May 2018

Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

30 May 2018

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 November 2018

Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 November 2018

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=57751

28 November 2018

Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Res

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinogen polymorphisms are not associated with the risk of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solid phase radioimmunoassays for human C-reactive protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinogen after coronary angioplasty as a risk factor for restenosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of cerebral blood flow in response to changes in blood viscosity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implication of fibrate therapy for homocysteine

1 reference

https://pubmed.ncbi.nlm.nih.gov/11806795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/CVM-2-4-195

0 references

Dimensions Publication ID

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24805756&oldid=1623014370"